Growing R&D activities in biopharmaceutical companies, expanding consumer base, and increasing adoption of software solutions for clinical trials are the primary factors expected to foster the growth of the global e-clinical solution software market during the forecast period, 2019–2026. Rapid adoption of technological advancements in the clinical trial field, such as electronic data capture and increasing prevalence of Wi-Fi connectivity, is expected to present potential growth opportunities for e-clinical software solutions in the future.
Increasing number of customers for e-clinical software solutions and increasing government grants to substantiate clinical trials are expected to drive the e-clinical solution software market growth. The requirement for effective clinical solutions drives the need to analyze and track clinical data. Additionally, the need to manage efficient clinical development processes is further expected to positively influence market growth in the near future.
The global e-clinical solution market can be segmented by product, delivery mode, end user, and region.
On the basis of product, the e-clinical market can be segmented into clinical analytic platform, clinical trial management system (CTMS), electronic data capture (EDC), clinical data integration platform, safety solutions, and others. EDC and CTMS are expected to drive the e-clinical solution market due to the enhanced flexibility, speed and other benefits associated with them, which aid in reducing drug development costs.
Based on delivery mode, the e-clinical market can be segmented into cloud-based, web hosted and licensed enterprises. Cloud-based and web-based solutions are expected to gain traction, owing to their improved performance and reliability, which prevent long deployment cycles, subsequently minimizing upfront investments and eliminating high infrastructure costs
By end user, the e-clinical market can be segmented into hospitals, CROs, medical device manufacturers, and others. Clinical trial activities are considered to be key corporate assets offering evidence of efficacy and safety of drugs’ potential economic value. Thus, sponsors and CROs are projected to constantly identify and deliver new ways in clinical research, which will surge the adoption of EDC through e-clinical solutions.
Geographically, the global e-clinical solution software market can be segmented into North America, Europe, Asia Pacific, and Latin America, the Middle East & Africa (LAMEA).
North America is expected to witness dynamic growth in the e-clinical solution software market due to the increasing number of clinical trials, R&D activities, and growing government regulations for clinical trials. Europe is expected to witness significant growth in the clinical solution software market, owing to the increasing number of clinical trial regulations that will harmonize the assessment and supervision processes for clinical trials throughout the European Union. Furthermore, the European Medicines Agency (EMA) would maintain the information system, in association with the Member States and the European Commission.
The Asia Pacific e-clinical solution software market is projected to witness rapid growth, owing to the increasing participation of developing economies in clinical trials. The significant trend of outsourcing e-clinical solutions in growing economies such as Taiwan, Korea, and India, owing to low operational costs and larger customer base, is further accelerating market growth in the region.
The LAMEA region is expected to witness considerable growth in the e-clinical solution software market during the forecast period, owing to the region’s racial diversity, which plays a vital role considering the site selection for studies, owing to the prevalence of significant diseases in particular groups.
Some of the key players operating in the e-clinical solution software market are MedNet Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.), Bioclinica Inc (U.S.) and others.